A Cohort Study of Nevirapine Tolerance in Clinical Practice: French Aquitaine Cohort, 1997–1999
Authors:
Open Access
- 15 November 2002
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (10) , 1231-1237
Abstract
We performed a retrospective study to evaluate, under routine circumstances, the tolerance and immunovirological changes associated with antiretrovirKeywords
This publication has 17 references indexed in Scilit:
- Failure of a Short-Term Prednisone Regimen to Prevent Nevirapine-Associated Rash: A Double-Blind Placebo-Controlled Trial: The GESIDA 09/99 StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapyAIDS, 2001
- Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapyAIDS, 2001
- Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1The Lancet, 2001
- Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroidsAIDS, 2000
- Prednisolone does not prevent the occurrence of nevirapine-induced rashesAIDS, 1999
- Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapineAIDS, 1999
- A Randomized, Double-Blind Trial on the Use of a Triple Combination Including Nevirapine, a Nonnucleoside Reverse Transcriptase HIV Inhibitor, in Antiretroviral-Naive Patients With Advanced DiseaseJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 InfectionAnnals of Internal Medicine, 1996
- A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patientsAIDS, 1996